文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Development of EMA401 as an orally-administered, highly-selective angiotensin II type 2 receptor antagonist for the treatment of neuropathic pain.

作者信息

McCarthy T

机构信息

Chief Executive Officer & Managing Director, Spinifex Pharmaceuticals, Victoria, Australia.

出版信息

J Peripher Nerv Syst. 2014 Oct;19 Suppl 2:S13-4. doi: 10.1111/jns.12080_4.

DOI:10.1111/jns.12080_4
PMID:25269730
Abstract
摘要

相似文献

[1]
Development of EMA401 as an orally-administered, highly-selective angiotensin II type 2 receptor antagonist for the treatment of neuropathic pain.

J Peripher Nerv Syst. 2014-10

[2]
EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial.

Lancet. 2014-2-5

[3]
Angiotensin II type 2-receptor: new clinically validated target in the treatment of neuropathic pain.

Clin Pharmacol Ther. 2014-12-20

[4]
Efficacy and safety of EMA401 in peripheral neuropathic pain: results of 2 randomised, double-blind, phase 2 studies in patients with postherpetic neuralgia and painful diabetic neuropathy.

Pain. 2021-10-1

[5]
Small molecule angiotensin II type 2 receptor (AT₂R) antagonists as novel analgesics for neuropathic pain: comparative pharmacokinetics, radioligand binding, and efficacy in rats.

Pain Med. 2013-3-14

[6]
New drug treatment reduces chronic pain following shingles.

J Pain Palliat Care Pharmacother. 2014-6

[7]
Selective small molecule angiotensin II type 2 receptor antagonists for neuropathic pain: preclinical and clinical studies.

Pain. 2016-2

[8]
Non-clinical characterization of the disposition of EMA401, a novel small molecule angiotensin II type 2 receptor (AT2R) antagonist.

Biopharm Drug Dispos. 2020-4

[9]
Targeting angiotensin II type 2 receptor pathways to treat neuropathic pain and inflammatory pain.

Expert Opin Ther Targets. 2015-1

[10]
Angiotensin II: from blood pressure to pain control.

Lancet. 2014-5-10

引用本文的文献

[1]
Mirogabalin and emerging therapies for diabetic neuropathy.

J Pain Res. 2018-8-22

[2]
EMA401: an old antagonist of the AT2R for a new indication in neuropathic pain.

J Pain Res. 2017-2-20

[3]
Rational drug design and synthesis of molecules targeting the angiotensin II type 1 and type 2 receptors.

Molecules. 2015-3-2

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索